Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients

Transplantation Proceedings

Volumn 34, Issue 5, 2002, Pages 1540-1541

  Jain, A K B ^a,b   Venkataramanan, R ^a   Shapiro, R ^a   Scantlebury, V P ^a   Potdar, S ^a   Bonham, C A ^a   Pokharna, R ^a   Rohal, S ^a   Ragni, M ^b   Fung, J ^a  

^a Department of Surgery ^*  (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; INDINAVIR; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NELFINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; STEROID; TACROLIMUS; ZALCITABINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG METABOLISM; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; ARTICLE; DRUG INTERACTION; IMMUNOLOGY; MORTALITY; SURVIVAL RATE;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG INTERACTIONS; HIV INFECTIONS; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; SURVIVAL RATE; TACROLIMUS; HUMANS;

EID: 0035993626     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03011-7     Document Type: Conference Paper

References (4)